Community/Retail

Pharmacists play an important role in educating patients and other health care practitioners on the signs and symptoms of C. difficile infection.

Paying close attention to the pharmacy’s operational and financial success does not have to come at the expense of quality patient care.

Lotrimin is indicated for the treatment of several common skin infections, such as athlete's foot, jock itch, and ringworm.

Investigators found that an additional hour of sleep correlated with a 26% decrease in an infant’s risk of being overweight.

Terrasil Shingles Skincare helps to alleviate pain, itching, burning, and irritation associated with shingles.

Vraylar is an atypical antipsychotic indicated for the treatment of adult patients with schizophrenia and for manic, mixed, or depressive episodes for patients with bipolar I disorder.

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses the challenges that lie ahead as we move into the third year of the COVID-19 pandemic, as well as other major developments on the horizon for pharmacists in 2022.

Prevalence of type 2 diabetes has been found higher in people with bipolar disorder, schizophrenia, and major depression compared to the general population.

Universal school-based depression screening shows promise addressing mental health conditions in students.

Cold sores are usually caused by herpes simplex virus type 1 and herpes simplex virus type 2.

Bevespi is indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.

The Bruise Remedy gel contains a botanical formula to relieve and soothe bruising.

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses what stands out as the biggest challenge from the past year and what role USP and pharmacists had in overcoming that challenge.

Luciano Costa, MD, PhD, associate director for clinical research at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, on the safety and efficacy of Dara-KRd in the treatment of patients with newly diagnosed multiple myeloma.

The first and only orally disintegrating tablet form of glycopyrrolate, the product will be launched in early 2022.

Mean changes from baseline in weight, fasting glucose, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were similar between lumateperone and placebo.

Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH), discusses how the work of the NIH ORWH impacts pharmacy practice.

The Board of Trustees of APhA addresses 5 areas in their statement, including importance of wellbeing, root causes of pharmacist burnout, pharmacy benefit manager issues, need for provider status, and some potential solutions.

The updated oath has entered into the modern era with more inclusive and contemporary language.

Help patients choose appropriate medications and direct them to a physician, when necessary

Ten quiz questions to assess your knowledge on common symptoms and treatments for ectopic pregnancy.

Mononucleosis isn't as contagious as some infections, such as the common cold.

Investigators in a clinical study evaluating the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in children aged 6 months to under 5 years noted that their research will continue with new changes.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity, addresses disparities occurring in diabetes care among racial and ethnic populations.

A panel of experts discuss the future of psychedelic medicine and the role of the pharmacy in that future.

Study may help guide COVID-19 vaccination strategies for patients with blood disorders.

Researchers to explore possible approaches for designing small molecule therapeutics to combat depression.

Fetal alcohol syndrome causes brain damage and growth problems.

Study shows moderately reduced efficacy of the Moderna COVID-19 vaccine over time against Delta infection, which supports current booster dose recommendations.

Major metabolites for cannabinoids may interfere with two families of enzymes that help metabolize a wide range of drugs prescribed for a variety of conditions.